Huma Therapeutics supplies GDm-Health to Birmingham Women's and Children's
- Birmingham Women's and Children's NHS Foundation Trust
- West Midlands
- Below threshold - without competition
- 20 April 2026 to 20 April 2027
Birmingham Women's and Children's NHS Foundation Trust is paying Huma Therapeutics for a year's subscription to GDm-Health. The software lets the trust's clinicians monitor patients with gestational diabetes remotely, with their data brought together for clinical review.
The trust awarded the £12,500 subscription directly in April 2026, without a competition. It runs to April 2027.
Contract ends April 2027
- What
- Remote patient monitoring and virtual ward technology
- Supplier
- Huma Therapeutics Limited
- Value
- £12,500
- How it was bought
- Below threshold - without competition
- Dates and next
- Apr 2026 to Apr 2027